These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 18006841

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Identification of a peptide ligand recognizing dysfunctional endothelial cells for targeting atherosclerosis.
    Thapa N, Hong HY, Sangeetha P, Kim IS, Yoo J, Rhee K, Oh GT, Kwon IC, Lee BH.
    J Control Release; 2008 Oct 06; 131(1):27-33. PubMed ID: 18680772
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome.
    Maeda N, Takeuchi Y, Takada M, Sadzuka Y, Namba Y, Oku N.
    J Control Release; 2004 Nov 05; 100(1):41-52. PubMed ID: 15491809
    [Abstract] [Full Text] [Related]

  • 45. A new phage-display tumor-homing peptide fused to antiangiogenic peptide generates a novel bioactive molecule with antimelanoma activity.
    Matsuo AL, Juliano MA, Figueiredo CR, Batista WL, Tanaka AS, Travassos LR.
    Mol Cancer Res; 2011 Nov 05; 9(11):1471-8. PubMed ID: 21900362
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Peptide-mediated transcytosis of phage display vectors in MDCK cells.
    Ivanenkov VV, Menon AG.
    Biochem Biophys Res Commun; 2000 Sep 16; 276(1):251-7. PubMed ID: 11006114
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Identification of a novel peptide ligand of human vascular endothelia growth factor receptor 3 for targeted tumour diagnosis and therapy.
    Qin X, Wan Y, Li M, Xue X, Wu S, Zhang C, You Y, Wang W, Jiang C, Liu Y, Zhu W, Ran Y, Zhang Z, Han W, Zhang Y.
    J Biochem; 2007 Jul 16; 142(1):79-85. PubMed ID: 17517791
    [Abstract] [Full Text] [Related]

  • 50. Phage peptide display.
    Newton J, Deutscher SL.
    Handb Exp Pharmacol; 2008 Jul 16; (185 Pt 2):145-63. PubMed ID: 18626602
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Potential role of vascular targeted therapy to combat against tumor.
    Chen B, Jin H, Wu K.
    Expert Opin Drug Deliv; 2009 Jul 16; 6(7):719-26. PubMed ID: 19538038
    [Abstract] [Full Text] [Related]

  • 53. Using in vivo biopanning for the development of radiation-guided drug delivery systems.
    Jaboin JJ, Han Z, Hallahan DE.
    Methods Mol Biol; 2009 Jul 16; 542():285-300. PubMed ID: 19565908
    [Abstract] [Full Text] [Related]

  • 54. Inhibition of tumor growth by RGD peptide-directed delivery of truncated tissue factor to the tumor vasculature.
    Kessler T, Bieker R, Padró T, Schwöppe C, Persigehl T, Bremer C, Kreuter M, Berdel WE, Mesters RM.
    Clin Cancer Res; 2005 Sep 01; 11(17):6317-24. PubMed ID: 16144936
    [Abstract] [Full Text] [Related]

  • 55. Novel peptides functionally targeting in vivo human lung cancer discovered by in vivo peptide displayed phage screening.
    Lee KJ, Lee JH, Chung HK, Choi J, Park J, Park SS, Ju EJ, Park J, Shin SH, Park HJ, Ko EJ, Suh N, Kim I, Hwang JJ, Song SY, Jeong SY, Choi EK.
    Amino Acids; 2015 Feb 01; 47(2):281-9. PubMed ID: 25366491
    [Abstract] [Full Text] [Related]

  • 56. Improved therapeutic responses for liposomal doxorubicin targeted via thrombospondin peptidomimetics versus untargeted doxorubicin.
    Rivera-Fillat MP, Reig F, Martínez EM, Grau-Oliete MR.
    J Pept Sci; 2010 Jul 01; 16(7):315-21. PubMed ID: 20552567
    [Abstract] [Full Text] [Related]

  • 57. Identification of a met-binding peptide from a phage display library.
    Zhao P, Grabinski T, Gao C, Skinner RS, Giambernardi T, Su Y, Hudson E, Resau J, Gross M, Vande Woude GF, Hay R, Cao B.
    Clin Cancer Res; 2007 Oct 15; 13(20):6049-55. PubMed ID: 17947467
    [Abstract] [Full Text] [Related]

  • 58. Improved therapeutic efficacy of doxorubicin through conjugation with a novel peptide drug delivery technology (Vectocell).
    Meyer-Losic F, Quinonero J, Dubois V, Alluis B, Dechambre M, Michel M, Cailler F, Fernandez AM, Trouet A, Kearsey J.
    J Med Chem; 2006 Nov 16; 49(23):6908-16. PubMed ID: 17154520
    [Abstract] [Full Text] [Related]

  • 59. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
    Li X, Ding L, Xu Y, Wang Y, Ping Q.
    Int J Pharm; 2009 May 21; 373(1-2):116-23. PubMed ID: 19429296
    [Abstract] [Full Text] [Related]

  • 60. A novel peptide specifically targeting ovarian cancer identified by in vivo phage display.
    Ma C, Yin G, Yan D, He X, Zhang L, Wei Y, Huang Z.
    J Pept Sci; 2013 Dec 21; 19(12):730-6. PubMed ID: 24105738
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.